BACKGROUND: Syndrome Z describes the interaction of obstructive sleep apnoea (OSA) with the metabolic syndrome. PURPOSE OF STUDY: A pilot study to determine the prevalence of syndrome Z in a teaching hospital in Singapore. METHODS: Patients (age > or =18 years) recruited for this prospective study had to satisfy three of the following five inclusion criteria: fasting glucose >6.1 mmol/l, blood pressure >/=130/85 mm Hg, HDL cholesterol <1.04 mmol/l in men and <1.2 mmol/l in women, triglycerides > or =1.7 mmol/l, and a waist circumference >102 cm in men and >88 cm in women. All subjects underwent standard overnight polysomnography. Overnight fasting glucose and lipid levels were measured and baseline anthropometric data recorded. All sleep studies were scored and reported by a sleep physician. OSA was deemed to be present if the respiratory disturbance index (RDI) was > or =5, with mild, moderate and severe categories classified according to the Chicago criteria. RESULTS: There were 24 patients (19 males and five females) of whom 10 were Chinese, eight Malay and five of Indian origin, with one other. Mean age was 48+/-13.5 years, mean body mass index was 34.9+/-6.1 kg/m2 and mean waist circumference was 111.3+/-15.7 cm. 23 (95.8%) of the patients had OSA with a mean RDI of 39.6+/-22.4 events/h with 15 patients (62.5%) in the severe category. The five patients who fulfilled all five criteria for diagnosis of the metabolic syndrome had severe OSA. CONCLUSION: The prevalence of OSA in our studied population exhibiting the metabolic syndrome is very high. Therefore, a polysomnogram should always be considered for this subset of patients.
BACKGROUND: Syndrome Z describes the interaction of obstructive sleep apnoea (OSA) with the metabolic syndrome. PURPOSE OF STUDY: A pilot study to determine the prevalence of syndrome Z in a teaching hospital in Singapore. METHODS:Patients (age > or =18 years) recruited for this prospective study had to satisfy three of the following five inclusion criteria: fasting glucose >6.1 mmol/l, blood pressure >/=130/85 mm Hg, HDL cholesterol <1.04 mmol/l in men and <1.2 mmol/l in women, triglycerides > or =1.7 mmol/l, and a waist circumference >102 cm in men and >88 cm in women. All subjects underwent standard overnight polysomnography. Overnight fasting glucose and lipid levels were measured and baseline anthropometric data recorded. All sleep studies were scored and reported by a sleep physician. OSA was deemed to be present if the respiratory disturbance index (RDI) was > or =5, with mild, moderate and severe categories classified according to the Chicago criteria. RESULTS: There were 24 patients (19 males and five females) of whom 10 were Chinese, eight Malay and five of Indian origin, with one other. Mean age was 48+/-13.5 years, mean body mass index was 34.9+/-6.1 kg/m2 and mean waist circumference was 111.3+/-15.7 cm. 23 (95.8%) of the patients had OSA with a mean RDI of 39.6+/-22.4 events/h with 15 patients (62.5%) in the severe category. The five patients who fulfilled all five criteria for diagnosis of the metabolic syndrome had severe OSA. CONCLUSION: The prevalence of OSA in our studied population exhibiting the metabolic syndrome is very high. Therefore, a polysomnogram should always be considered for this subset of patients.
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson Journal: Am J Respir Crit Care Med Date: 2002-07-15 Impact factor: 21.405
Authors: J Krieger; W T McNicholas; P Levy; W De Backer; N Douglas; O Marrone; J Montserrat; J H Peter; D Rodenstein Journal: Eur Respir J Date: 2002-12 Impact factor: 16.671
Authors: F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering Journal: JAMA Date: 2000-04-12 Impact factor: 56.272
Authors: E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405
Authors: Jamie C M Lam; Bing Lam; Chi-Leung Lam; Daniel Fong; Julie K L Wang; Hung-Fat Tse; Karen S L Lam; Mary S M Ip Journal: Respir Med Date: 2005-12-05 Impact factor: 3.415
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: Mary S M Ip; Bing Lam; Matthew M T Ng; Wah Kit Lam; Kenneth W T Tsang; Karen S L Lam Journal: Am J Respir Crit Care Med Date: 2002-03-01 Impact factor: 21.405
Authors: Felipe X Cepeda; Edgar Toschi-Dias; Cristiane Maki-Nunes; Maria Urbana P B Rondon; Maria Janieire N N Alves; Ana Maria F W Braga; Daniel G Martinez; Luciano F Drager; Geraldo Lorenzi-Filho; Carlos E Negrao; Ivani C Trombetta Journal: Sleep Date: 2015-07-01 Impact factor: 5.849
Authors: Ivani C Trombetta; Virend K Somers; Cristiane Maki-Nunes; Luciano F Drager; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Maria Urbana P B Rondon; Maíta G Bechara; Geraldo Lorenzi-Filho; Carlos E Negrão Journal: Sleep Date: 2010-09 Impact factor: 5.849
Authors: Luciano F Drager; Heno F Lopes; Cristiane Maki-Nunes; Ivani C Trombetta; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Jonathan C Jun; Carlos E Negrão; Eduardo M Krieger; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho Journal: PLoS One Date: 2010-08-11 Impact factor: 3.240
Authors: Eduardo Araujo Perez; Luis Vicente Franco Oliveira; Wilson Rodrigues Freitas; Carlos Alberto Malheiros; Elias Jirjoss Ilias; Anderson Soares Silva; Jessica Julioti Urbano; Patricia Clemente Oliveira; Felipe X Cepeda; Luciana M M Sampaio; Ivani C Trombetta; Humberto Delle; Daniel Gianella Neto; Sergio Roberto Nacif; Roberto Stirbulov Journal: Diabetol Metab Syndr Date: 2017-09-20 Impact factor: 3.320